[Therapy of recurrent oral aphthae with thymopoetin pentapeptide].
Five patients suffering from recurrent oral aphthae and one patient with Behçet's disease were treated with thymopoetin pentapeptide injections for 6 weeks. Although some immune parameters showed a tendency toward normalization no clinical improvement was observed.
D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000627:therapeutic use*; D012008:Recurrence; D013281:Stomatitis, Aphthous / Q000188:drug therapy* / Q000276:immunology; D016305:Thymopentin; D013946:Thymopoietins / Q000627:therapeutic use*; D013951:Thymus Hormones / Q000627:therapeutic use*
D010446:Peptide Fragments; D013946:Thymopoietins; D013951:Thymus Hormones; D016305:Thymopentin
Therapie der rezidivierenden oralen Aphthen mit Thymopoetin-Pentapeptid.